Bottom line
LOGSX vs PPH: the short answer
LOGSX (Live Oak Health Sciences Fund) and PPH (VanEck Pharmaceutical ETF) are both mutual funds.
PPH is cheaper at 0.36% vs 1.04% — a difference of $68 a year per $10,000 invested.
Over five years, PPH returned +11.3% a year vs +8.1% for LOGSX.
Updated Nov 19, 2026
LOGSX vs PPH side by side
| LOGSX | PPH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Oak Associates | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.04% | 0.36% |
| Annual cost per $10k | $104 | $36 |
| 10-yr cost on $10k (prospectus) | $1,271 | $456 |
| Max front load | — | None |
| 12b-1 fee | — | — |
| 1-yr return | +19.6% | +21.9% |
| 5-yr return (annualized) | +8.1% | +11.3% |
| 10-yr return (annualized) | +7.3% | +6.7% |
| Best quarter | +13.4% | +16.5% |
| Worst quarter | −13.1% | −15.0% |
| Net assets (fund) | $56.1M | $879.5M |
| Number of holdings | 28 | 26 |
| Portfolio turnover | 24% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LOGSX | PPH | Difference |
|---|---|---|---|
| 2025 | +19.6% | +21.9% | −2.3% |
| 2024 | +0.2% | +8.1% | −8.0% |
| 2023 | +1.2% | +6.9% | −5.7% |
| 2022 | +3.7% | +2.6% | +1.1% |
| 2021 | +17.5% | +18.3% | −0.8% |
| 2020 | +6.0% | +5.2% | +0.8% |
| 2019 | +19.0% | +19.1% | −0.2% |
| 2018 | −4.0% | −5.7% | +1.7% |
| 2017 | +13.4% | +15.4% | −2.0% |
| 2016 | −0.4% | −17.8% | +17.4% |
Source: Fund prospectus bar charts
Holdings overlap
8 of LOGSX's top 25 holdings also appear in PPH's top 25.
| Holding | LOGSX | PPH |
|---|---|---|
| Novartis Ag | 4.67% | 10.63% |
| Mckesson Corp | 4.53% | 4.12% |
| Cencora Inc | 4.46% | 3.36% |
| Bristol-myers Squibb Company | 4.02% | 4.47% |
| Johnson & Johnson | 3.77% | 4.35% |
| Merck & Company Inc | 3.16% | 9.85% |
| Novo Nordisk A/s | 2.51% | 5.37% |
| Eli Lilly & Company | 1.99% | 20.23% |
Source: SEC Form N-PORT
LOGSX top 10
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
PPH top 10
- Eli Lilly & Co — 20.23%
- Novartis AG — 10.63%
- Merck & Co Inc — 9.85%
- Novo Nordisk A/S — 5.37%
- AbbVie Inc — 4.57%
- Pfizer Inc — 4.51%
- Bristol-Myers Squibb Co — 4.47%
- Gsk Plc — 4.42%
- Johnson & Johnson — 4.35%
- AstraZeneca PLC — 4.33%
FAQ
What is the difference between LOGSX and PPH?
Which is cheaper, LOGSX or PPH?
Should I own both LOGSX and PPH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.